Laboratory evaluation of the liat HIV quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1616-1621

  Scott, Lesley ^a   Gous, Natasha ^a   Carmona, Sergio ^a,b   Stevens, Wendy ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; BIOASSAY; BIOTECHNOLOGY; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; PATIENT COMPLIANCE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOUTH AFRICA; VIRAL LOAD TESTING; BLOOD; EVALUATION STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; BLOOD; HIV INFECTIONS; HIV-1; HUMANS; POINT-OF-CARE TESTING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VIRAL LOAD;

EID: 84928041896     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03325-14     Document Type: Article

References (28)

1. AIDSInfo. 13 November 2014, posting date. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: laboratory testing plasma HIV-1 RNA (Viral Load) and CD4 count monitoring. http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0/.
2. Chu C, Selwyn PA. 2010. Diagnosis and initial management of acute HIV infection. Am Fam Physician 81:1239-1244.
3. Delamare C, Burgard M, Mayaux MJ, Blanche S, Doussin A, Ivanoff S, Chaix ML, Khan C, Rouzioux C. 1997. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 15: 121-125. http://dx.doi.org/10.1097/00042560-199706010-00004.
4. Read JS. 2007. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 120:e1547-e1562. http://dx.doi .org/10.1542/peds.2007-2951.
5. AIDSInfo. 5 March 2015, posting date. Guidelines for the use of antiretroviral agents in pediatric HIV infection: diagnosis of HIV infection in infants and children. http://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv-guidelines/55/diagnosis-of-hiv-infection-in-infants-and-children.
6. Stevens WS, Scott LE, Crowe SM. 2010. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J Infect Dis 201(Suppl 1):S16-S26. http://dx.doi.org/10.1086/650392.
7. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W. 2007. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis 44:128-134. http://dx.doi.org/10.1086/510073.
8. Bygrave H. 27 January 2014, posting date. HIV viral load testing in Africa-no longer why but how? PLoS Blog. http://blogs.plos.org/speakingofmedicine/2 014/01/27/hiv-viral-load-testing-africa-longer/.
9. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin Infect Dis 49:976-981. http://dx.doi.org/10.1086/605502.
10. Johannessen A, Troseid M, Calmy A. 2009. Dried blood spots can expand access to virological monitoring of HIV treatment in resourcelimited settings. J Antimicrob Chemother 64:1126-1129. http://dx.doi .org/10.1093/jac/dkp353.
11. Neogi U, Gupta S, Rodridges R, Sahoo PN, Rao SD, Rewari BB, Shastri S, Costa AD, Shet A. 2012. Dried blood spot HIV-1 RNA quantification: a useful tool for viral load monitoring among HIV-infected individuals in India. Indian J Med Res 136:956-962.
12. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de Mendoza C, Garcia-Lerma JG. 2008. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J Antimicrob Chemother 61:1217-1220. http://dx.doi.org/10.1093/jac/dkn100.
13. Schito M, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW. 2012. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis 205(Suppl 2):S169-S180. http://dx.doi.org/10.1093/infdis/jis044.
14. UNITAID. June 2013, posting date. UNITAID HIV/AIDS diagnostic technology landscape, 3rd ed. http://www.unitaid.eu/en/resources-2/news/9-uncategorised/345-technical-reports.
15. UNITAID. June 2014, posting date. HIV/AIDS diagnostics technology landscape, 4th ed. http://www.unitaid.eu/images/marketdynamics/ publications/UNITAID-HIV-Diagnostic-Landscape-4th-edition.pdf.
16. Ritchie AV, Ushiro-Lumb I, Edemaga D, Joshi HA, De Ruiter A, Szumilin E, Jendrulek I, McGuire M, Goel N, Sharma PI, Allain JP, Lee HH. 2014. SAMBA HIV semi-quantitative test, a new point-of-care viral load monitoring assay for resource-limited settings. J Clin Microbiol 52: 3377-3383. http://dx.doi.org/10.1128/JCM.00593-14.
17. Coombs R, Dragavon J, Hargb S, Mangalindan O, Bremer J, Jennings C, Chen L, Tian Y, Chen S. 2011. Validation of a novel Lab-in-a-Tube analyzer and single-tube system for simple/rapid HIV-1 RNA quantification, poster 657. 18th Conf Retrovir Opportun Infect, Boston, M.A.
18. Tanriverdi S, Chen L, Chen S. 2010. A rapid and automated sample-toresult HIV load test for near-patient application. J Infect Dis 201(Suppl 1):S52-S58. http://dx.doi.org/10.1086/650387.
19. Scott LE, Carmona S, Gous N, Horsfield P, Mackay M, Stevens W. 2012. Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing. J Clin Microbiol 50:4083-4086. http://dx.doi.org/10 .1128/JCM.01355-12.
20. Brambilla DJ, Granger S, Jennings C, Bremer JW. 2001. Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche Amplicor HIV-1 Monitor assays. J Clin Microbiol 39: 1121-1123. http://dx.doi.org/10.1128/JCM.39.3.1121-1123.2001.
21. Lin LI-K. 2000.Anote on the concordance correlation coefficient. Biometrics 56:324-325. http://dx.doi.org/10.1111/j.0006-341X.2000.00324.x.
22. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i: 307-307.
23. Scott LE, Galpin JS, Glencross DK. 2003. Multiple method comparison: statistical model using percentage similarity. Cytom B Clin Cytom 54:46-53. http://dx.doi.org/10.1002/cyto.b.10016.
24. McBride GB. 2005. A proposal for strength of agreement criteria for Lin.s.Concordance correlation coefficient. NIWA client report HAM2005-062. Report for Ministry of Health, Hamilton, New Zealand.
25. Papathanasopoulos MA, Cilliers T, Morris L, Mokili JL, Dowling W, Birx DL, McCutchan FE. 2002. Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS Res Hum Retrovir 18:879-886. http://dx.doi.org/10 .1089/08892220260190362.
26. Castel AD, Befus M, Willis S, Griffin A, West T, Hader S, Greenberg AE. 2012. Use of the community viral load as a population-based biomarker of HIV burden. AIDS 26:345-353. http://dx.doi.org/10.1097/QAD.0b013e32834de5fe.
27. Kessler HH, Jungkind D, Stelzl E, Direnzo S, Vellimedu SK, Pierer K, Santner B, Marth E. 1999. Evaluation of AMPLILINK software for the COBAS AMPLICOR system. J Clin Microbiol 37:436-437.
28. McNeil DG. 25 August 2014, posting date. AIDS progress in South Africa is in peril. The New York Times. http://www.nytimes.com/2014/08/26/health/aids-south-africa-success-pepfar.html?-r-1.